Zinc Sulfate Eye Solution |
Eye-Sed |
Clinical Trial: Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers
This study is currently recruiting patients.
Verified by Imperial College London September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Reduction in NSAID related gut damage | Drug: Zinc carnosine | Phase I |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Official Title: Use of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers Taking Non Steroidal Anti Inflammatory Drugs (NSAIDS):
Secondary Outcomes: Differences in dyspepsia score; Differences in faecal calprotectin
Expected Total Enrollment: 12
Study start: May 2005
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- Age 18-35
Exclusion Criteria:
- Conditions known to alter intestinal permeability eg previous bowel surgery, caeliac disease
Conditions where NSAIDs are contraindicated eg asthma, renal failure, heart failure
Diabetes
Any other serious ilness
Location and Contact Information
United Kingdom
Imperial College, London, W12 0NN, United Kingdom; Recruiting
Asif Mahmood, MRCP, Sub-Investigator
Raymond Playford, FRCP PhD, Principal Investigator
Raymond Playford, MD PhD, Principal Investigator, Imperial College
More Information
Last Updated: September 7, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00149149
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Eye-Sed (Drug Digest)
- Zinc Sulfate Eye Solution (Drug Digest)

Not Signed In -


